Pharmacogenomics and Pharmacokinetics of Aspirin in Preeclampsia Prevention
Circulation Research · 2025
DOI: 10.1161/circresaha.124.325699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Kenean Getaneh Tlaye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology (K.G.T., G.G.W., L.C., R.Z., X.W., L.N.-H., B.W.L., Y.W., L.C.P., C.C.W.), The Chinese University of Hong Ko…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Aspirin, Pharmacogenetics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: It has become evident that some women develop preeclampsia despite aspirin. This study aimed to examine how such aspirin nonresponsiveness develops in high-risk preeclampsia pregnancies by exploring the role of genetic polymorphisms and aspirin metabolism. METHODS: The study involved pregnant women who developed preeclampsia despite low-dose aspirin and those who did not. First, we conducted a pharmacogenomic association study exploring the association of potential genetic variants with aspirin nonresponsiveness. Next, we analyzed the rate of enzymatic aspirin hydrolysis in maternal plasma. The extent of placental exposure to acetylsalicylic acid and its bioactive metabolites, that is, salicylic acid and gentisic acid, was determined by liquid chromatography-mass spectrometry. The expressions of placental AMEs (aspirin metabolizing enzymes), that is, GLYAT (glycine-N-acyltransferase), UGT1A6 (UDP glucuronosyltransferase family 1 member A6), CYP2E1 (cytochrome P450 family 2 subfamily E member 1), and NAT2 (N-acetyltransferase 2) were analyzed by quantitative reverse transcription polymerase chain reaction, immunohistochemistry staining, and enzyme-linked immunosorbent assay. Finally, the effects of AMEs were further studied on HTR-8/SVneo (an immortalized human trophoblast cell line derived from first-trimester placenta) and hPCTB (human primary cytotrophoblast) cells. RESULTS: Our genetic study showed that single-nucleotide polymorphisms (SNPs) of genes involved in aspirin pharmacokinetics and pharmacodynamics were not associated with aspirin nonresponsiveness in preeclampsia. Rates of aspirin hydrolysis in maternal plasma and the concentrations of acetylsalicylic acid, salicylic acid, and gentisic acid in the placenta did not differ between aspirin-responsive and aspirin-nonresponsive women. Intriguingly, GLYAT was significantly upregulated in the aspirin-nonresponsive placenta and associated with aspirin nonresponsiveness. This overexpression of GLYAT was found to diminish the proangiogenic, anti-inflammatory, and antisenescence effects of salicylic acid in HTR-8/SVneo and hPCTB cells. CONCLUSIONS: Our study revealed that maternal genetic factors and plasma aspirin hydrolysis are not among the decisive factors in determining the effectiveness of low-dose aspirin in preventing preeclampsia among high-risk women. Instead, placental GLYAT appears to play a key role by limiting the effect of salicylic acid in the placenta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology (K.G.T., G.G.W., L.C., R.Z., X.W., L.N.-H., B.W.L., Y.W., L.C.P., C.C.W.), The Chinese University of Hong Kong, Shatin, Hong Kong.
- Department of Biomedical Sciences, Wolkite University, Ethiopia (G.G.W.).
- School of Biomedical Sciences (K.C.-Y.W., H.C.S.), The Chinese University of Hong Kong, Shatin, Hong Kong.
- University Research Facility in Life Sciences, The Hong Kong Polytechnic University Hong Kong, Hung Hom, Hong Kong, China (P.K.S.).
- Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China (M.Z.).
- Department of Psychiatry (H.C.S.), The Chinese University of Hong Kong, Shatin, Hong Kong.
ORCID-Profile: Lu Chen, Ruqun Zheng, Xueqin Wang, Long Nguyen-Hoang, Mei Zhong, Bo Wah Leung, Yu Huang, Yao Wang, Liona C Poon, Chi Chiu Wang
Zitieren
APA
Tlaye, K. G., Woldeamanuel, G. G., Wong, K. C., Chen, L., Zheng, R., So, P. K., Wang, X., Nguyen-Hoang, L., Zhong, M., So, H. C., Leung, B. W., Huang, Y., Wang, Y., Poon, L. C., & Wang, C. C. (2025). Pharmacogenomics and Pharmacokinetics of Aspirin in Preeclampsia Prevention. Circulation Research. https://doi.org/10.1161/circresaha.124.325699
Vancouver
Tlaye KG, Woldeamanuel GG, Wong KC, Chen L, Zheng R, So PK, et al. Pharmacogenomics and Pharmacokinetics of Aspirin in Preeclampsia Prevention. Circulation Research. 2025. doi:10.1161/circresaha.124.325699
BibTeX
@article{Tlaye2025,
author = {Tlaye, Kenean Getaneh and Woldeamanuel, Gashaw Garedew and Wong, Kenneth Chi-Yin and Chen, Lu and Zheng, Ruqun and So, Pui Kin and Wang, Xueqin and Nguyen-Hoang, Long and Zhong, Mei and So, Hon Cheong and Leung, Bo Wah and Huang, Yu and Wang, Yao and Poon, Liona C and Wang, Chi Chiu},
title = {Pharmacogenomics and Pharmacokinetics of Aspirin in Preeclampsia Prevention},
journal = {Circulation Research},
year = {2025},
doi = {10.1161/circresaha.124.325699}
}
EUVIMED